SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma

Clinical trial NCT04803877 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04803877
Sponsor: Sarcoma Alliance for Research through Collaboration
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Osteosarcoma Osteosarcoma in Children Osteosarcoma Recurrent Osteosarcoma Metastatic

Start date: 2021-06-04
Primary completion: 2025-11-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.